Jump Trading’s Standard BioTools LAB Stock Holding History

Jump Trading’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-13,000	Closed	-$173K	–	469
2019 Q1	$173K	Buy	+13,000	New	+$137K	0.06%	408

Other funds holding LAB

EIP

Easterly Investment Partners Beverly, Massachusetts $1.31B AUM 18.17% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jump Trading's LAB Position: Q2 2019 in Review

Jump Trading sold out of Standard BioTools (LAB) in Q2 2019, closing a stake of 13,000 shares — an estimated $173K sold.

Jump Trading first reported a position in LAB in Q1 2019 and held it in 1 quarter. The position peaked at $173K in Q1 2019. 135 funds tracked by Wall St. Rank hold LAB as of Q2 2019.

Jump Trading reported no remaining Standard BioTools position as of Q2 2019 after selling out during the quarter.
Jump Trading sold 13,000 Standard BioTools shares in Q2 2019, an estimated $173K.
Jump Trading first reported a position in Standard BioTools in Q1 2019 and held it in 1 quarter.
Jump Trading's Standard BioTools position peaked at $173K in Q1 2019.
135 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2019.

Based on Jump Trading's 13F filing for Q2 2019, filed 14 Aug 2019.